Add to Favourites
To login click here
Oncotelic Therapeutics, Inc. has announced a strategic partnership with Vectara, a company specializing in Natural Language Understanding (NLU) technologies, to accelerate the development of novel therapies for the treatment of cancer, infectious disease, and aging. The partnership is intended to help scientists and researchers quickly and accurately sift through large volumes of research papers and publications to find valuable data points that could aid in the innovation and creation of new or improved immunotherapies. The solution is expected to speed up pharmaceutical research and potentially lead to groundbreaking solutions for drug discovery and formulation.
